| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Biology, Pathobiology, and Genetics |
The Institute for Biomolecular Structure and Function and Department of Biological Sciences, Hunter College and Graduate School, City University of New York, New York, New York
Requests for reprints: Jill Bargonetti, Department of Biological Sciences, City University of New York-Hunter College, 695 Park Avenue, New York, NY 10021. Phone: 212-650-3519; Fax: 212-772-5227; E-mail: bargonetti{at}genectr.hunter.cuny.edu.
The tumor suppressor p53 is a potent transcription factor of which the ability to mediate transcription is inhibited through an interaction with the oncoprotein mouse double minute 2 (Mdm2). The present study has tested the hypothesis that Mdm2 inhibits the p53 response in normally growing cells by binding to chromatin-associated p53. Using chromatin immunoprecipitation, we show that Mdm2 localizes with p53 at its responsive elements on the waf1 and mdm2 genes in human cell lines expressing p53, but not in cell lines lacking p53 expression, indicating that Mdm2 is recruited to regions of DNA in a p53-dependent manner. Interestingly, our results show a decrease of Mdm2 protein associated with p53-responsive elements on the waf1 and mdm2 genes when p53-induced transcription is activated either by DNA damage or through controlled overexpression of p53. Rapid activation of p53 transcriptional activity before increasing p53 protein levels was observed with addition of either small-molecule inhibitors to disrupt the p53-Mdm2 interaction or small interfering RNA to mdm2. These findings indicate Mdm2 transiently localizes with p53 at responsive elements and suggest that latent p53 results from the recruitment of Mdm2 to chromatin. (Cancer Res 2006; 66(7): 3463-70)
This article has been cited by other articles:
![]() |
M. Malmlof, G. Paajarvi, J. Hogberg, and U. Stenius Mdm2 as a Sensitive and Mechanistically Informative Marker for Genotoxicity Induced by Benzo[a]pyrene and Dibenzo[a,l]pyrene Toxicol. Sci., April 1, 2008; 102(2): 232 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Wawrzynow, A. Zylicz, M. Wallace, T. Hupp, and M. Zylicz MDM2 Chaperones the p53 Tumor Suppressor J. Biol. Chem., November 9, 2007; 282(45): 32603 - 32612. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Brooks, M. Li, and W. Gu Mechanistic Studies of MDM2-mediated Ubiquitination in p53 Regulation J. Biol. Chem., August 3, 2007; 282(31): 22804 - 22815. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |